The GAP-related domain of the neurofibromatosis type 1 gene product interacts with ras p21 - PubMed

The GAP-related domain of the neurofibromatosis type 1 gene product interacts with ras p21

G A Martin et al. Cell. 1990.

Abstract

The neurofibromatosis type 1 (NF1) protein contains a region of significant sequence similarity to ras p21 GTPase-activating protein (GAP) and the yeast IRA1 gene product. A fragment of NF1 cDNA encoding the GAP-related domain (NF1 GRD) was expressed, immunoaffinity purified, and assayed for effects on N-ras p21 GTPase activity. The GTPase of wild-type ras p21 was stimulated by NF1 GRD, but oncogenic mutants of ras p21 (Asp-12 and Val-12) were unaffected, and the GTPase of an effector mutant (Ala-38) was only weakly stimulated. NF1 GRD also down-regulated RAS function in S. cerevisiae. The affinity of NF1 GRD for ras p21 was estimated to be 250 nM: this is more than 20-fold higher than the affinity of GAP for ras p21. However, its specific activity was about 30 times lower. These kinetic measurements suggest that NF1 may be a significant regulator of ras p21 activity, particularly at low ras p21 concentrations.

Similar articles

• The NF1 locus encodes a protein functionally related to mammalian GAP and yeast IRA proteins.

  Ballester R, Marchuk D, Boguski M, Saulino A, Letcher R, Wigler M, Collins F. Ballester R, et al. Cell. 1990 Nov 16;63(4):851-9. doi: 10.1016/0092-8674(90)90151-4. Cell. 1990. PMID: 2121371

• The catalytic domain of the neurofibromatosis type 1 gene product stimulates ras GTPase and complements ira mutants of S. cerevisiae.

  Xu GF, Lin B, Tanaka K, Dunn D, Wood D, Gesteland R, White R, Weiss R, Tamanoi F. Xu GF, et al. Cell. 1990 Nov 16;63(4):835-41. doi: 10.1016/0092-8674(90)90149-9. Cell. 1990. PMID: 2121369

• A conserved alternative splice in the von Recklinghausen neurofibromatosis (NF1) gene produces two neurofibromin isoforms, both of which have GTPase-activating protein activity.

  Andersen LB, Ballester R, Marchuk DA, Chang E, Gutmann DH, Saulino AM, Camonis J, Wigler M, Collins FS. Andersen LB, et al. Mol Cell Biol. 1993 Jan;13(1):487-95. doi: 10.1128/mcb.13.1.487-495.1993. Mol Cell Biol. 1993. PMID: 8417346 Free PMC article.

• [Heterogeneity of GTPase-activating proteins for Ras in the regulation of Ras signal transduction pathway].

  Hattori S, Baba H. Hattori S, et al. Yakugaku Zasshi. 1996 Jan;116(1):21-38. doi: 10.1248/yakushi1947.116.1_21. Yakugaku Zasshi. 1996. PMID: 8699317 Review. Japanese.

• The kinetic mechanism of the GAP-activated GTPase of p21 ras.

  Moore KJ, Lowe PN, Eccleston JF. Moore KJ, et al. Philos Trans R Soc Lond B Biol Sci. 1992 Apr 29;336(1276):49-53; discussion 53-4. doi: 10.1098/rstb.1992.0043. Philos Trans R Soc Lond B Biol Sci. 1992. PMID: 1351296 Review.

Cited by

• Structural Insights into the SPRED1-Neurofibromin-KRAS Complex and Disruption of SPRED1-Neurofibromin Interaction by Oncogenic EGFR.

  Yan W, Markegard E, Dharmaiah S, Urisman A, Drew M, Esposito D, Scheffzek K, Nissley DV, McCormick F, Simanshu DK. Yan W, et al. Cell Rep. 2020 Jul 21;32(3):107909. doi: 10.1016/j.celrep.2020.107909. Cell Rep. 2020. PMID: 32697994 Free PMC article.

• MicroRNA-193b enhances tumor progression via down regulation of neurofibromin 1.

  Lenarduzzi M, Hui AB, Alajez NM, Shi W, Williams J, Yue S, O'Sullivan B, Liu FF. Lenarduzzi M, et al. PLoS One. 2013;8(1):e53765. doi: 10.1371/journal.pone.0053765. Epub 2013 Jan 15. PLoS One. 2013. PMID: 23335975 Free PMC article.

• A shared molecular mechanism underlies the human rasopathies Legius syndrome and Neurofibromatosis-1.

  Stowe IB, Mercado EL, Stowe TR, Bell EL, Oses-Prieto JA, Hernández H, Burlingame AL, McCormick F. Stowe IB, et al. Genes Dev. 2012 Jul 1;26(13):1421-6. doi: 10.1101/gad.190876.112. Genes Dev. 2012. PMID: 22751498 Free PMC article.

• Brain tumors in Neurofibromatosis type 1.

  Costa AA, Gutmann DH. Costa AA, et al. Neurooncol Adv. 2019 Oct 26;1(1):vdz040. doi: 10.1093/noajnl/vdz040. eCollection 2019 May-Dec. Neurooncol Adv. 2019. PMID: 32642668 Free PMC article. Review.

• Cotargeting MNK and MEK kinases induces the regression of NF1-mutant cancers.

  Lock R, Ingraham R, Maertens O, Miller AL, Weledji N, Legius E, Konicek BM, Yan SC, Graff JR, Cichowski K. Lock R, et al. J Clin Invest. 2016 Jun 1;126(6):2181-90. doi: 10.1172/JCI85183. Epub 2016 May 9. J Clin Invest. 2016. PMID: 27159396 Free PMC article.

Publication types

MeSH terms

Substances

LinkOut - more resources

• Full Text Sources

  • Elsevier Science

• Other Literature Sources

  • The Lens - Patent Citations Database

• Molecular Biology Databases

  • GlyGen glycoinformatics resource
  • Saccharomyces Genome Database

• Research Materials

  • NCI CPTC Antibody Characterization Program

• Miscellaneous

  • NCI CPTAC Assay Portal